Papers
2
Total Citations
9
H-Index
2
About
Shu-Yu Wu is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC), a malignancy with particularly high prevalence in Taiwan. Dr. Wu has made pivotal contributions to the debate on minimally invasive versus open surgical approaches for advanced UTUC. In a landmark 2024 multi-center retrospective study, Wu and colleagues demonstrated that laparoscopic and robotic nephroureterectomy with bladder cuff excision can achieve comparable oncologic outcomes to open surgery even in patients with T3T4 disease, challenging the prevailing caution against minimally invasive techniques for locally advanced tumors. This work, already garnering 5 citations, provides critical evidence for surgeons treating high-risk UTUC. Additionally, Wu led a nationwide collaborative study in Taiwan—a UTUC endemic area—evaluating segmental ureterectomy outcomes, showing that this nephron-sparing approach is a viable option for selected patients with mid- and distal ureteral tumors. With 4 citations, this study offers region-specific data that fills a crucial gap in the literature. Dr. Wu’s research directly informs clinical guidelines and surgical decision-making in a high-incidence population, establishing them as a key authority on UTUC management.
Research Focus
Key Achievements
Top Papers
- 1
- 2